🔎 Trials Near Me

Home › B-Cell Lymphoma › Texas › Dallas

Pag-aaral pangklinika para sa B-Cell Lymphoma sa Dallas, TX

Isang pag-aaral para sa B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

Nagre-recruitPhase 1/2
  • University of Texas Southwestern Medical Center, Dallas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07439653

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1
  • University of Texas Southwestern, Dallas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2
  • Baylor University Medical Center, Dallas
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2
  • UT Southwestern Medical Center, Dallas
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Nagre-recruitPhase 1/2
  • University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Nagre-recruitPhase 1/2
  • Baylor Scott & White Research Institute, Texas Oncology, Dallas
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2025 · NCT06343311

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1
  • University of Texas, Southwestern, Dallas
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.